Market Cap 102.78B
Revenue (ttm) 403.43B
Net Income (ttm) 4.76B
EPS (ttm) N/A
PE Ratio 21.58
Forward PE 19.73
Profit Margin 1.18%
Debt to Equity Ratio -3.83
Volume 888,800
Avg Vol 958,676
Day's Range N/A - N/A
Shares Out 116.59M
Stochastic %K 13%
Beta 0.30
Analysts Strong Sell
Price Target $984.29

Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions;...

Industry: Medical Distribution
Sector: Healthcare
Phone: 972 446 4800
Address:
6555 State Highway 161, Irving, United States
JamesTaulman
JamesTaulman Sep. 9 at 7:41 AM
TUE 9/8: $MCK – Got Turned Back From the 10 DMA Today – Not Good Latest Chart Update: MCK 9:55 PM – We are currently reporting on this stock as an active holding and continue to monitor the stock closely for any technical SELL SIGNALS. The focus always remains on price/volume action around key support levels, including the 10 DMA, 50 DMA, and any nearby trendline or ROUND-$ support. https://buyingbreakouts.com/tue-9-8-mck-got-turned-back-from-the-10-dma-today-not-good/
0 · Reply
MavrickPete
MavrickPete Sep. 8 at 1:32 AM
$MCK Stock around $908, only 9% below its $999 52-week high,..
0 · Reply
MAFFHEW_MCCONAGHEY
MAFFHEW_MCCONAGHEY Sep. 4 at 1:19 PM
$MCK @Kosmos709 this one nice
0 · Reply
Nosh
Nosh Sep. 2 at 5:06 PM
$MCK Went heavy into this yesterday...would like to add but it's doing well. Looking at a few others and have actually found some and added to those. They are not sexy names. But it's saving my ass and my mind. Sell these when the trader believes a stable bottom is forming and go back into momo names. GLTY.
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Sep. 2 at 1:57 PM
0 · Reply
Nosh
Nosh Sep. 1 at 6:41 PM
$MCK New opener....charts are good to $1000 so there is that. Then...it works best in this type of environment...actually it is the best over the past few VOLATILITY spikes or downward moves. Don't post often - but it should be a great place to park cash - and then rotate it out and use it later elsewhere when it's already peaked over that $1000. GLTY.
0 · Reply
PanicSeller8
PanicSeller8 Sep. 1 at 5:48 PM
$MCK Always so strong when market is wobbly.
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Sep. 1 at 3:41 PM
$MCK Working also $JNJ
0 · Reply
OldManGrumble
OldManGrumble Sep. 1 at 2:27 PM
$MCK $WM $DUK $KO $PG Playing a little defense
1 · Reply
OnlyFibs
OnlyFibs Sep. 1 at 1:54 AM
$MCK | McKesson Corporation (Healthcare / Healthcare Services & Distribution 🏥) $MCK is compressing tightly into a major wedge apex on the 8H chart following a steady ascending channel recovery. Price action is holding directly above the high-volume profile node at $844.60, coiling beneath descending resistance. With volatility squeezing near the upper profile boundaries, an explosive move is imminent as price prepares to test overhead liquidity toward $900.00+. Key Technical Levels: • Confirmation Trigger: $864.00 🚀 • Pivot Support: $844.60 🐂 • Overhead Target 1: $900.00 🎯 • Overhead Target 2: $997.90 💰 • Downside Risk Level: $760.00 🐻 • Stop Loss: $832.00 🔴 Flow & Market Bias: Structure: 8H Wedge Compression / High-Volume Profile Consolidation Bias: Bullish above $844.60 #MCK #optionsflow #stockmarket #technicalanalysis #swingtrading #hovdid
0 · Reply
Latest News on MCK
McKesson signs agreement to acquire Precision Medicine Group

2026-08-25T12:20:17.000Z - 19 days ago

McKesson signs agreement to acquire Precision Medicine Group


McKesson price target raised to $1,000 from $925 at Barclays

2026-08-19T09:30:10.000Z - 25 days ago

McKesson price target raised to $1,000 from $925 at Barclays


McKesson initiated with a Sector Perform at RBC Capital

2026-08-19T09:10:23.000Z - 25 days ago

McKesson initiated with a Sector Perform at RBC Capital


McKesson price target raised to $933 from $812 at Wells Fargo

2026-08-11T11:05:19.000Z - 4 weeks ago

McKesson price target raised to $933 from $812 at Wells Fargo


McKesson price target raised to $1,015 from $955 at Baird

2026-08-06T13:26:16.000Z - 5 weeks ago

McKesson price target raised to $1,015 from $955 at Baird


McKesson price target raised to $1,006 from $989 at TD Cowen

2026-08-06T12:51:14.000Z - 5 weeks ago

McKesson price target raised to $1,006 from $989 at TD Cowen


McKesson price target raised to $1,080 from $1,050 at UBS

2026-08-06T12:43:27.000Z - 5 weeks ago

McKesson price target raised to $1,080 from $1,050 at UBS


McKesson price target raised to $905 from $885 at Mizuho

2026-08-06T11:23:04.000Z - 5 weeks ago

McKesson price target raised to $905 from $885 at Mizuho


McKesson Earnings Call Transcript: Q1 2027

Aug 5, 2026, 4:30 PM EDT - 5 weeks ago

McKesson Earnings Call Transcript: Q1 2027


McKesson Earnings release: Q1 2027

Aug 5, 2026, 4:30 PM EDT - 5 weeks ago

McKesson Earnings release: Q1 2027


McKesson Slides: Q1 2027

Aug 5, 2026, 4:30 PM EDT - 5 weeks ago

McKesson Slides: Q1 2027


McKesson Quarterly report: Q1 2027

Aug 5, 2026, 4:30 PM EDT - 5 weeks ago

McKesson Quarterly report: Q1 2027


McKesson reports Q1 adjusted EPS $9.93, consensus $9.54

2026-08-05T20:17:36.000Z - 5 weeks ago

McKesson reports Q1 adjusted EPS $9.93, consensus $9.54


McKesson price target raised to $1,000 from $945 at Citi

2026-07-24T10:46:10.000Z - 7 weeks ago

McKesson price target raised to $1,000 from $945 at Citi


McKesson Proxy statement: Proxy filing

Jun 30, 2026, 8:00 AM EDT - 2 months ago

McKesson Proxy statement: Proxy filing


McKesson Proxy statement: Proxy filing

Jun 12, 2026, 8:00 AM EDT - 3 months ago

McKesson Proxy statement: Proxy filing


McKesson Proxy statement: Proxy filing

Jun 12, 2026, 8:00 AM EDT - 3 months ago

McKesson Proxy statement: Proxy filing


McKesson Earnings Call Transcript: Q4 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

McKesson Earnings Call Transcript: Q4 2026


McKesson Earnings release: Q4 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

McKesson Earnings release: Q4 2026


McKesson Slides: Q4 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

McKesson Slides: Q4 2026


McKesson Annual report: Q4 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

McKesson Annual report: Q4 2026


McKesson Annual report: Q4 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

McKesson Annual report: Q4 2026


McKesson Corporation Declares Quarterly Dividend

Apr 22, 2026, 8:00 AM EDT - 4 months ago

McKesson Corporation Declares Quarterly Dividend


Is McKesson Stock Still A High-Conviction Compounder?

Apr 21, 2026, 12:26 PM EDT - 4 months ago

Is McKesson Stock Still A High-Conviction Compounder?


McKesson to Sell Stake of Medical-Surgical Unit to Apollo

Apr 20, 2026, 8:58 AM EDT - 4 months ago

McKesson to Sell Stake of Medical-Surgical Unit to Apollo

APO


McKesson Transcript: Leerink Global Healthcare Conference 2026

Mar 11, 2026, 10:00 AM EDT - 6 months ago

McKesson Transcript: Leerink Global Healthcare Conference 2026


McKesson Announces Planned CFO Transition

Mar 5, 2026, 8:10 AM EST - 6 months ago

McKesson Announces Planned CFO Transition


See How Institutional Inflows Make McKesson Fly

Feb 25, 2026, 8:26 AM EST - 6 months ago

See How Institutional Inflows Make McKesson Fly


How McKesson Stock Surged 17% In A Day

Feb 6, 2026, 11:25 AM EST - 7 months ago

How McKesson Stock Surged 17% In A Day


McKesson boosts 2026 profit forecast amid specialty drug growth

Feb 4, 2026, 7:01 PM EST - 7 months ago

McKesson boosts 2026 profit forecast amid specialty drug growth


McKesson Earnings Call Transcript: Q3 2026

Feb 4, 2026, 4:30 PM EST - 7 months ago

McKesson Earnings Call Transcript: Q3 2026


McKesson Quarterly report: Q3 2026

Feb 4, 2026, 4:30 PM EST - 7 months ago

McKesson Quarterly report: Q3 2026


McKesson Earnings release: Q3 2026

Feb 4, 2026, 4:30 PM EST - 7 months ago

McKesson Earnings release: Q3 2026


McKesson Slides: Q3 2026

Feb 4, 2026, 4:30 PM EST - 7 months ago

McKesson Slides: Q3 2026


McKesson Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 12:45 PM EST - 8 months ago

McKesson Transcript: 44th Annual J.P. Morgan Healthcare Conference


McKesson Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 12:45 PM EST - 8 months ago

McKesson Slides: 44th Annual J.P. Morgan Healthcare Conference


Final Trades: Lockheed Martin, QXO and McKesson Corporation

Jan 5, 2026, 1:46 PM EST - 8 months ago

Final Trades: Lockheed Martin, QXO and McKesson Corporation

LMT QXO


McKesson Transcript: UBS Global Healthcare Conference 2025

Nov 10, 2025, 9:30 AM EST - 10 months ago

McKesson Transcript: UBS Global Healthcare Conference 2025


McKesson Earnings Call Transcript: Q2 2026

Nov 5, 2025, 4:30 PM EST - 10 months ago

McKesson Earnings Call Transcript: Q2 2026


McKesson Quarterly report: Q2 2026

Nov 5, 2025, 4:30 PM EST - 10 months ago

McKesson Quarterly report: Q2 2026


McKesson Earnings release: Q2 2026

Nov 5, 2025, 4:30 PM EST - 10 months ago

McKesson Earnings release: Q2 2026


McKesson Slides: Q2 2026

Nov 5, 2025, 4:30 PM EST - 10 months ago

McKesson Slides: Q2 2026


The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

Oct 14, 2025, 12:47 PM EDT - 11 months ago

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

COR WFC


How to trade the health care break out

Oct 6, 2025, 2:24 PM EDT - 11 months ago

How to trade the health care break out

MRK UNH VEEV XBI XLV


See How McKesson Shares Rise with Money Flows

Oct 1, 2025, 7:28 AM EDT - 11 months ago

See How McKesson Shares Rise with Money Flows


McKesson Transcript: Investor Day 2025

Sep 23, 2025, 9:30 AM EDT - 11 months ago

McKesson Transcript: Investor Day 2025


McKesson Slides: FY 2025

Sep 23, 2025, 9:30 AM EDT - 11 months ago

McKesson Slides: FY 2025


McKesson Announces New Organizational Structure

Sep 18, 2025, 8:00 AM EDT - 12 months ago

McKesson Announces New Organizational Structure


McKesson Earnings Call Transcript: Q1 2026

Aug 6, 2025, 4:30 PM EDT - 1 year ago

McKesson Earnings Call Transcript: Q1 2026


McKesson Earnings release: Q1 2026

Aug 6, 2025, 4:30 PM EDT - 1 year ago

McKesson Earnings release: Q1 2026


McKesson Quarterly report: Q1 2026

Aug 6, 2025, 4:30 PM EDT - 1 year ago

McKesson Quarterly report: Q1 2026


McKesson Slides: Q1 2026

Aug 6, 2025, 4:30 PM EDT - 1 year ago

McKesson Slides: Q1 2026


McKesson Proxy statement: Proxy Filing

Jul 2, 2025, 8:00 AM EDT - 1 year ago

McKesson Proxy statement: Proxy Filing


McKesson Proxy statement: Proxy Filing

Jun 20, 2025, 8:00 AM EDT - 1 year ago

McKesson Proxy statement: Proxy Filing


McKesson Proxy statement: Proxy Filing

Jun 20, 2025, 8:00 AM EDT - 1 year ago

McKesson Proxy statement: Proxy Filing


JamesTaulman
JamesTaulman Sep. 9 at 7:41 AM
TUE 9/8: $MCK – Got Turned Back From the 10 DMA Today – Not Good Latest Chart Update: MCK 9:55 PM – We are currently reporting on this stock as an active holding and continue to monitor the stock closely for any technical SELL SIGNALS. The focus always remains on price/volume action around key support levels, including the 10 DMA, 50 DMA, and any nearby trendline or ROUND-$ support. https://buyingbreakouts.com/tue-9-8-mck-got-turned-back-from-the-10-dma-today-not-good/
0 · Reply
MavrickPete
MavrickPete Sep. 8 at 1:32 AM
$MCK Stock around $908, only 9% below its $999 52-week high,..
0 · Reply
MAFFHEW_MCCONAGHEY
MAFFHEW_MCCONAGHEY Sep. 4 at 1:19 PM
$MCK @Kosmos709 this one nice
0 · Reply
Nosh
Nosh Sep. 2 at 5:06 PM
$MCK Went heavy into this yesterday...would like to add but it's doing well. Looking at a few others and have actually found some and added to those. They are not sexy names. But it's saving my ass and my mind. Sell these when the trader believes a stable bottom is forming and go back into momo names. GLTY.
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Sep. 2 at 1:57 PM
0 · Reply
Nosh
Nosh Sep. 1 at 6:41 PM
$MCK New opener....charts are good to $1000 so there is that. Then...it works best in this type of environment...actually it is the best over the past few VOLATILITY spikes or downward moves. Don't post often - but it should be a great place to park cash - and then rotate it out and use it later elsewhere when it's already peaked over that $1000. GLTY.
0 · Reply
PanicSeller8
PanicSeller8 Sep. 1 at 5:48 PM
$MCK Always so strong when market is wobbly.
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Sep. 1 at 3:41 PM
$MCK Working also $JNJ
0 · Reply
OldManGrumble
OldManGrumble Sep. 1 at 2:27 PM
$MCK $WM $DUK $KO $PG Playing a little defense
1 · Reply
OnlyFibs
OnlyFibs Sep. 1 at 1:54 AM
$MCK | McKesson Corporation (Healthcare / Healthcare Services & Distribution 🏥) $MCK is compressing tightly into a major wedge apex on the 8H chart following a steady ascending channel recovery. Price action is holding directly above the high-volume profile node at $844.60, coiling beneath descending resistance. With volatility squeezing near the upper profile boundaries, an explosive move is imminent as price prepares to test overhead liquidity toward $900.00+. Key Technical Levels: • Confirmation Trigger: $864.00 🚀 • Pivot Support: $844.60 🐂 • Overhead Target 1: $900.00 🎯 • Overhead Target 2: $997.90 💰 • Downside Risk Level: $760.00 🐻 • Stop Loss: $832.00 🔴 Flow & Market Bias: Structure: 8H Wedge Compression / High-Volume Profile Consolidation Bias: Bullish above $844.60 #MCK #optionsflow #stockmarket #technicalanalysis #swingtrading #hovdid
0 · Reply
Doozio
Doozio Aug. 26 at 11:34 PM
$MCK chop chops huckleberries n cup n handles.
0 · Reply
topstockalerts
topstockalerts Aug. 25 at 8:46 PM
McKesson agreed to acquire Precision Medicine Group for approximately $2.25 billion, deepening its oncology strategy. Precision Medicine provides clinical research and biopharma commercialization services, including biomarker intelligence, laboratory services, clinical trial execution, market-access consulting and commercialization support. CEO Brian Tyler called the deal another significant step in McKesson’s oncology and multispecialty strategy. The acquisition follows a broader shift toward higher-growth, higher-margin businesses, with the Oncology and Multispecialty unit’s revenue rising 33% in the latest quarter. Barclays recently raised its price target on McKesson to $1,000, while the company increased its quarterly dividend 15% to $0.94 per share. McKesson shares rose to a session high of $902.13, outperforming the broader market and moving closer to their 52-week high of $999. $MCK
0 · Reply
notreload_ai
notreload_ai Aug. 25 at 7:32 PM
Morgan Stanley calls $MCK $2.25B Precision Medicine buy a logical CRO addition unlocking a $25B oncology market. Overweight, $977 target. https://notreload.xyz/xy/morgan-stanley-mck-2-25b-deal-strengthens-oncology/
0 · Reply
cynicaloptimist
cynicaloptimist Aug. 25 at 7:00 PM
$MCK Defensive positioning in effect
0 · Reply
OldManGrumble
OldManGrumble Aug. 25 at 1:53 AM
$MCK 3.
0 · Reply
CapitalMonk
CapitalMonk Aug. 22 at 3:23 AM
$MCK Price: $858.90 (+2.40%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.80% RSI: 57.3 | Momentum: Moderate Volume: -17.4% vs avg Volatility: 2.42% Support: $810.88 | Resistance: $912.50 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
MaverikIT
MaverikIT Aug. 21 at 3:59 PM
@IsabellaDC @Jblack500 @cynicaloptimist @BustaCapital @WAJeff @No_Face_character $LLY getting her hair$ done again @ $ULTA ready for the weekend $MCK $HCA ....
1 · Reply
AngelBarhorst176
AngelBarhorst176 Aug. 20 at 7:31 AM
$EQNR $VRT $TT $VLO $MCK Equinor remains leveraged to European energy markets, Vertiv benefits from AI data-center power and cooling demand, Trane Technologies benefits from HVAC and building efficiency spending, Valero benefits from refining economics, and McKesson benefits from pharmaceutical distribution demand. I'm watching energy prices, data-center capex, HVAC orders, crack spreads, and healthcare volumes.
0 · Reply
LibertarianTreehugger
LibertarianTreehugger Aug. 19 at 3:57 PM
"Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits: https://www.fool.com/investing/2026/08/19/trumpflation-is-real-and-getting-worse-here-are-2/ $COR $MCK
0 · Reply
cynicaloptimist
cynicaloptimist Aug. 18 at 7:59 PM
$LLY $MCK foundation to weather momentum storms. $XLV
1 · Reply
DidYouReadThis
DidYouReadThis Aug. 14 at 1:49 AM
For any #microcap #pharma #stock with a #new #FDAapproval, is there an #average #number of #quarters to #switch from -#negative to #positive #EPS? $BRK.B $MCK $LLY $MRK
0 · Reply
DanfromBAMA
DanfromBAMA Aug. 11 at 11:48 PM
$MCK upward trend. But I am dumb af tho
1 · Reply